Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000176649 | SCV000228338 | pathogenic | not provided | 2014-08-11 | criteria provided, single submitter | clinical testing | |
3billion, |
RCV001542687 | SCV002058955 | likely pathogenic | Congenital stationary night blindness 1C | 2022-01-03 | criteria provided, single submitter | clinical testing | Frameshift: predicted to result in a loss or disruption of normal protein function through protein truncation. Multiple pathogenic variants are reported in the predicted truncated region (PVS1_S). The variant has been reported to be associated with TRPM1 related disorder (ClinVar ID: VCV000195958). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000024, PM2_M). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline. |
Genomics England Pilot Project, |
RCV001542687 | SCV001760343 | pathogenic | Congenital stationary night blindness 1C | no assertion criteria provided | clinical testing |